New FDA Clearance fo...
Enhanced BIOFIRE®...
1st April 2019 Content supplied by: bioMérieux (Clinical Diagnostics)
Spotlight on Antimicrobial Stewardship with bioMérieux
Future generations need us to sustain antimicrobial efficacy and curb resistance – and appropriate use of antibiotics is key. Diagnostics play an essential role by providing actionable information to support decisions for antibiotic initiation, optimization and discontinuation.
To make the strongest impact possible, bioMérieux is committed to helping labs and healthcare professionals further improve antimicrobial stewardship. Here are a few highlights of what we have waiting for you at ECCMID:
At Stand No. #1.3
Some recent innovations:
- VITEK® 2 OPUS AST CARDS: One-card efficiency. More actionable results
- BIOFIRE® FILMARRAY® Pneumonia plus: Don’t let pneumonia bugs sneak by undetected!
- PhenoMATRIX™: Embedded interpretation intelligence for WASPLab®
At bioMérieux’s Integrated Symposium
Sunday, April 14 • 16:00-18:00 • Hall G
- With our expert speakers, explore the vital role of diagnostics in antimicrobial stewardship
Tags:
Date Published: 1st April 2019
Source article link: https://eccmid2019.biomerieux.com/?utm_source=rapid-microbio&utm_medium=web&utm_campaign=RM
New FDA Clearance for VITEK&
Enhanced BIOFIRE® Blood Culture
bioMérieux (clinical diagnostic applications)
Address:
Marcy L'Etoile
France
Tel: +[33] 4 78 87 20 00
Related news from bioMérieux (clinical diagnostic applications)
- Enhanced BIOFIRE® Blood Culture Identification 2 (BCID2) Panel Submitted for FDA Clearance
- New FDA Clearance for VITEK® MS: Expanded ID for Challenging Pathogens
- PhenoMATRIX™ for WASPLab®: AI for Sample Interpretation & Sorting
- BIOFIRE® FILMARRAY® Pneumonia Panels Gain FDA clearance and CE Marking
- bioMérieux and DIAGNOSTICS IS POWER at ECCMID 2018
- FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS
- FDA Clearance for BacT/ALERT® VIRTUO™ Fully Automated Blood Culture System
- bioMérieux Your Expert in Infectious Diseases at ECCMID 2017
- bioMérieux Awarded Multi-year Agreement with NHS for Bacterial Screening of Platelets
- New VITEK® MS Update Enables ID of Mycobacteria, Nocardia & Moulds
- VITEK® MS CE-Marked Database Expands to Include Mycobacteria, Nocardia and Moulds
- Lab Chooses WASPLab™ and VIRTUO™ for Full Microbiology Automation
- bioMérieux Buys Bioinformatics Company - Applied Maths
- bioMérieux and Illumina Launch NGS Service for Epidemiology
- FDA 510(k) Clearance for VIDAS® 3 - the New Generation of VIDAS®
- chromID® Salmonella Elite, Earlier Detection for Stool Samples
- FDA Approved VIDAS® C. difficile GDH is the 100th VIDAS® Assay
- Parvovirus B19 R-gene® Kit Detects and Quantifies B19 Genotypes
- bioMérieux Announces U.S. FDA Clearance for VITEK® MS
- bioMérieux Releases Etest® Ceftaroline